Literature DB >> 25053651

Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.

David W Volk1, David A Lewis2.   

Abstract

Cognitive dysfunction is a disabling and core feature of schizophrenia. Cognitive impairments have been linked to disturbances in inhibitory (gamma-aminobutyric acid [GABA]) neurons in the prefrontal cortex. Cognitive deficits are present well before the onset of psychotic symptoms and have been detected in early childhood with developmental delays reported during the first year of life. These data suggest that the pathogenetic process that produces dysfunction of prefrontal GABA neurons in schizophrenia may be related to altered prenatal development. Interestingly, adult postmortem schizophrenia brain tissue studies have provided evidence consistent with a disease process that affects different stages of prenatal development of specific subpopulations of prefrontal GABA neurons. Prenatal ontogeny (ie, birth, proliferation, migration, and phenotypic specification) of distinct subpopulations of cortical GABA neurons is differentially regulated by a host of transcription factors, chemokine receptors, and other molecular markers. In this review article, we propose a strategy to investigate how alterations in the expression of these developmental regulators of subpopulations of cortical GABA neurons may contribute to the pathogenesis of cortical GABA neuron dysfunction and consequently cognitive impairments in schizophrenia.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  GABA neuron; development; interneuron; parvalbumin; postmortem; prefrontal cortex; prenatal ontogeny; somatostatin

Mesh:

Year:  2014        PMID: 25053651      PMCID: PMC4133685          DOI: 10.1093/schbul/sbu111

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  83 in total

1.  Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy.

Authors:  Inma Cobos; Maria Elisa Calcagnotto; Alex J Vilaythong; Myo T Thwin; Jeffrey L Noebels; Scott C Baraban; John L R Rubenstein
Journal:  Nat Neurosci       Date:  2005-07-10       Impact factor: 24.884

2.  Morphine disrupts long-range synchrony of gamma oscillations in hippocampal slices.

Authors:  M A Whittington; R D Traub; H J Faulkner; J G Jefferys; K Chettiar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.

Authors:  T U Woo; J L Miller; D A Lewis
Journal:  Am J Psychiatry       Date:  1997-07       Impact factor: 18.112

4.  Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects.

Authors:  S A Anderson; D W Volk; D A Lewis
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

5.  Disruption of two novel genes by a translocation co-segregating with schizophrenia.

Authors:  J K Millar; J C Wilson-Annan; S Anderson; S Christie; M S Taylor; C A Semple; R S Devon; D M St Clair; W J Muir; D H Blackwood; D J Porteous
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes.

Authors:  S A Anderson; D D Eisenstat; L Shi; J L Rubenstein
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

7.  Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences.

Authors:  David V Hansen; Jan H Lui; Pierre Flandin; Kazuaki Yoshikawa; John L Rubenstein; Arturo Alvarez-Buylla; Arnold R Kriegstein
Journal:  Nat Neurosci       Date:  2013-10-06       Impact factor: 24.884

8.  Subcortical origins of human and monkey neocortical interneurons.

Authors:  Tong Ma; Congmin Wang; Lei Wang; Xing Zhou; Miao Tian; Qiangqiang Zhang; Yue Zhang; Jiwen Li; Zhidong Liu; Yuqun Cai; Fang Liu; Yan You; Chao Chen; Kenneth Campbell; Hongjun Song; Lan Ma; John L Rubenstein; Zhengang Yang
Journal:  Nat Neurosci       Date:  2013-10-06       Impact factor: 24.884

9.  Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum.

Authors:  L Sussel; O Marin; S Kimura; J L Rubenstein
Journal:  Development       Date:  1999-08       Impact factor: 6.868

10.  Child development risk factors for adult schizophrenia in the British 1946 birth cohort.

Authors:  P Jones; B Rodgers; R Murray; M Marmot
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

View more
  40 in total

Review 1.  Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Authors:  Haneul Noh; Zhicheng Shao; Joseph T Coyle; Sangmi Chung
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-28       Impact factor: 5.187

2.  Characterization of genome-wide association study data reveals spatiotemporal heterogeneity of mental disorders.

Authors:  Yulin Dai; Timothy D O'Brien; Guangsheng Pei; Zhongming Zhao; Peilin Jia
Journal:  BMC Med Genomics       Date:  2020-12-28       Impact factor: 3.063

3.  The Cytokine CXCL12 Promotes Basket Interneuron Inhibitory Synapses in the Medial Prefrontal Cortex.

Authors:  Pei-Rung Wu; Kathleen K A Cho; Daniel Vogt; Vikaas S Sohal; John L R Rubenstein
Journal:  Cereb Cortex       Date:  2017-09-01       Impact factor: 5.357

4.  Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders.

Authors:  D W Volk; A R Sampson; Y Zhang; J R Edelson; D A Lewis
Journal:  Psychol Med       Date:  2016-06-22       Impact factor: 7.723

5.  Infusions of Nerve Growth Factor Into the Developing Frontal Cortex Leads to Deficits in Behavioral Flexibility and Increased Perseverance.

Authors:  Sagar J Desai; Brian L Allman; Nagalingam Rajakumar
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

6.  Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.

Authors:  Antonio Ortega-Álvaro; Francisco Navarrete; Auxiliadora Aracil-Fernández; Daniela Navarro; Pere Berbel; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2015-04-21       Impact factor: 7.853

7.  Downregulation of parvalbumin expression in the prefrontal cortex during adolescence causes enduring prefrontal disinhibition in adulthood.

Authors:  Adriana Caballero; Eden Flores-Barrera; Daniel R Thomases; Kuei Y Tseng
Journal:  Neuropsychopharmacology       Date:  2020-05-13       Impact factor: 7.853

8.  Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course.

Authors:  Ravit Hadar; M Luisa Soto-Montenegro; Thomas Götz; Franziska Wieske; Reinhard Sohr; Manuel Desco; Clement Hamani; Ina Weiner; Javier Pascau; Christine Winter
Journal:  Schizophr Res       Date:  2015-06-06       Impact factor: 4.939

Review 9.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

10.  Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.

Authors:  David W Volk; Jessica R Edelson; David A Lewis
Journal:  Schizophr Res       Date:  2016-03-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.